Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

In addition to the scientific meeting, featuring twelve international plenary speakers, along with open papers and poster sessions, there will be two satellite events on Sunday 7 September - a hands-on clinical workshop on tendinopathy and a consensus meeting on outcome measures.

The meeting has proved highly popular and is now fully booked, but you can follow the meeting and join the discussion on Twitter using hashtag #Tendons2014.

The Symposium is co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

Speaking of the event, Prof Thompson says: "ISTS 2014 will pull together exciting plenary speakers, excellent scientists and expert clinicians in the inspiring surroundings of St Hilda's College to find new ways of treating painful and debilitating tendon disease. The meeting venue is full, but social media will take the conversations wider and further, and we will be posting video of the final discussion session."

The meeting proceedings will be published in the BJSM soon after the event.

For the first time in its three-edition history, the meeting is co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Prof Thompson has already spoken to BJSM about this year's Symposium and a podcast is online. This year's programme is also published.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.